PPP2R2A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.486200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.571400E-01
Normal-vs-Stage2
5.756600E-01
Normal-vs-Stage3
9.994800E-01
Normal-vs-Stage4
7.032200E-02
Stage1-vs-Stage2
5.817200E-01
Stage1-vs-Stage3
8.735000E-01
Stage1-vs-Stage4
1.501580E-01
Stage2-vs-Stage3
5.226600E-01
Stage2-vs-Stage4
2.922600E-01
Stage3-vs-Stage4
1.890620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.922200E-01
Normal-vs-AfricanAmerican
3.677200E-01
Normal-vs-Asian
5.784800E-01
Caucasian-vs-AfricanAmerican
5.091000E-01
Caucasian-vs-Asian
7.880600E-01
AfricanAmerican-vs-Asian
6.782400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.900800E-01
Normal-vs-Female
6.116800E-01
Male-vs-Female
5.675600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.204000E-01
Normal-vs-Age(41-60Yrs)
3.428000E-01
Normal-vs-Age(61-80Yrs)
7.920600E-01
Normal-vs-Age(81-100Yrs)
8.762800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.778200E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.678600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.156800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.160100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.431800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.672000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.618000E-01
Normal-vs-Daily Drinker
8.883200E-01
Normal-vs-Weekly Drinker
7.229000E-01
Normal-vs-Occasional Drinker
3.736400E-01
Normal-vs-Social Drinker
4.957200E-01
Non Drinker-vs-Daily Drinker
7.012800E-01
Non Drinker-vs-Weekly Drinker
5.121200E-01
Non Drinker-vs-Occasional Drinker
5.852500E-02
Non Drinker-vs-Social Drinker
1.490160E-01
Daily Drinker-vs-Weekly Drinker
3.480200E-01
Daily Drinker-vs-Occasional Drinker
3.460400E-02
Daily Drinker-vs-Social Drinker
9.572200E-02
Weekly Drinker-vs-Occasional Drinker
3.548200E-01
Weekly Drinker-vs-Social Drinker
5.365000E-01
Occasional Drinker-vs-Social Drinker
8.040400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.068600E-01
Normal-vs-Grade 2
2.154000E-02
Normal-vs-Grade 3
2.366300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.440830E-04
Grade 1-vs-Grade 3
1.018890E-04
Grade 1-vs-Grade 4
2.068600E-01
Grade 2-vs-Grade 3
3.373600E-01
Grade 2-vs-Grade 4
2.154000E-02
Grade 3-vs-Grade 4
2.366300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.924600E-01
Normal-vs-NonDiabetic
6.506200E-01
Diabetic-vs-NonDiabetic
3.022600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.601400E-01
Normal-vs-NoPancreatitis
7.136200E-01
Pancreatitis-vs-NoPancreatitis
2.663000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.793000E-01
Normal-vs-N1
5.936800E-01
N0-vs-N1
7.668600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.009400E-01
Normal-vs-TP53-NonMutant
9.591800E-01
TP53-Mutant-vs-TP53-NonMutant
2.102900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
